Connor, Clark & Lunn Investment Management (CC&L)’s Mirum Pharmaceuticals MIRM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $21.6M | Buy |
423,744
+67,468
| +19% | +$3.43M | 0.08% | 234 |
|
|
2025
Q1 | $16.1M | Buy |
356,276
+179,316
| +101% | +$8.08M | 0.07% | 230 |
|
|
2024
Q4 | $7.32M | Buy |
176,960
+109,585
| +163% | +$4.53M | 0.03% | 388 |
|
|
2024
Q3 | $2.63M | Buy |
67,375
+21,526
| +47% | +$840K | 0.01% | 605 |
|
|
2024
Q2 | $1.57M | Buy |
+45,849
| New | +$1.57M | 0.01% | 725 |
|
|
2024
Q1 | – | Sell |
-133,527
| Closed | -$3.94M | – | 1645 |
|
|
2023
Q4 | $3.94M | Buy |
133,527
+19,418
| +17% | +$573K | 0.02% | 495 |
|
|
2023
Q3 | $3.61M | Buy |
114,109
+76,369
| +202% | +$2.41M | 0.02% | 478 |
|
|
2023
Q2 | $976K | Buy |
+37,740
| New | +$976K | ﹤0.01% | 801 |
|
|
2022
Q4 | – | Sell |
-10,689
| Closed | -$225K | – | 1351 |
|
|
2022
Q3 | $225K | Sell |
10,689
-3,784
| -26% | -$79.7K | ﹤0.01% | 975 |
|
|
2022
Q2 | $282K | Sell |
14,473
-8,534
| -37% | -$166K | ﹤0.01% | 872 |
|
|
2022
Q1 | $507K | Sell |
23,007
-2,611
| -10% | -$57.5K | ﹤0.01% | 782 |
|
|
2021
Q4 | $409K | Buy |
+25,618
| New | +$409K | ﹤0.01% | 836 |
|